Adenosine A(2A) receptors in nonlocomotor features of Parkinson's disease: introduction.
Ongini
Ennio
E
Nicox Research Institute, Bresso, Milan, Italy. ongini@nicox.it
D058917:Adenosine A2 Receptor Antagonists; D000818:Animals; D000978:Antiparkinson Agents / Q000009:adverse effects / Q000627:therapeutic use; D002490:Central Nervous System / Q000187:drug effects / Q000503:physiopathology; D003863:Depression / Q000209:etiology; D004409:Dyskinesia, Drug-Induced / Q000209:etiology; D006801:Humans; D007024:Hypotension, Orthostatic / Q000209:etiology; D007980:Levodopa / Q000009:adverse effects / Q000627:therapeutic use; D010300:Parkinson Disease / Q000150:complications / Q000188:drug therapy / Q000503:physiopathology*; D043705:Receptor, Adenosine A2A / Q000378:metabolism*; D012893:Sleep Wake Disorders / Q000209:etiology
D058917:Adenosine A2 Receptor Antagonists; D000978:Antiparkinson Agents; D043705:Receptor, Adenosine A2A; D007980:Levodopa